If you have had individual or employer-sponsored health insurance for more than a few years, you have experienced the ritual: the annual renewal letter, the new premium amount, and the quiet calculation of how much more this will cost you per month.
The average American pays $300,000+ in health insurance premiums over their lifetime. Almost none of it comes back.
Why Premiums Keep Rising
1. Medical cost inflation. Healthcare costs in the United States rise faster than general inflation every year. New treatments, hospital consolidation, and pharmaceutical pricing all contribute to higher underlying costs.
2. Adverse selection spirals. When premiums rise, healthier people drop coverage or move to cheaper plans. This leaves a sicker pool, which drives costs higher, which raises premiums again. The cycle repeats.
3. Administrative overhead. Traditional insurers spend 10–25% of premium revenue on administrative costs: marketing, claims review, billing, prior authorization, and executive compensation. These costs do not contribute to your care.
4. Insurer profit margins. Publicly traded insurers are accountable to shareholders, not policyholders. Every dollar not paid in claims is potentially a dollar returned to shareholders.
What the ACA's MLR Rule Does (and Doesn't Do)
The Affordable Care Act requires large group plans to spend at least 85% of premiums on medical care and small group/individual plans to spend at least 80%. If an insurer exceeds these limits, it must issue rebates. This constrains — but does not eliminate — the profit extraction problem.
How the IPR Changes the Math
The Investment Premium Reserve does not reduce your medical costs or stop healthcare inflation. What it does is change who benefits from the years you stay healthy. Instead of your "good years" subsidizing insurer profit, 85–89% of every premium goes to your personal account. When your premiums go up — as they will — so does your annual IPR contribution.
[Placeholder — expand with premium trend data, historical premium increases by state, and projections of IPR growth relative to premium increases.]